Profile

Trading style
intraday
Motto
Ada SOP Baru Entry

Systems by MohdAzimBinSenen

Name
Gain
Drawdown
Performance
Fidelcrest Challenge Competition
Demo
1:100
MetaTrader 4
+0.00%
34.73%
Fidelcrest Challenge Competition performance
Fidelcrest Challenge Competition 2
Demo
1:100
MetaTrader 4
+26.82%
12.42%
Fidelcrest Challenge Competition 2 performance
Katipang
Demo
1:500
MetaTrader 4
+0.00%
0.00%
Katipang performance

Recent Posts

No data to display

MohdAzimBinSenen's Reviews

No data to display
Tools
Kalender Ekonomi
Jam pasar
Suku bunga
Kalender hari libur
Pasar Valas
Forex Volatility
Forex Correlation
Berita Forex
Analisis Forex
COT Data
Likuiditas
Kalkulator Forex
Forex Heat Map
Indikator ekonomi
Komunitas
Komunitas
Sistems
Most Popular Systems
Strategies
Kontes
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviu
Pialang
Perusahaan Prop Trading
VPS Services
Signal Providers
EA Programming Services
Program Afiliasi
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Bursa Kripto
Kursus trading
Pialang
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions
Siaran Pers
Platform
Widget
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.